Blogs about Biotechnology, Pharmaceutical and Healthcare

00:15 EDT 22nd September 2014 | BioPortfolio

Read the latest opinions - blogs from pharmaceutical and life science industry experts.

Showing News Articles 1–25 of 59,000+

Sunday 21st September 2014

China Remains Pie In Sky For Indian Drug Makers

As Chinese president Xi Jinping wraps up his first visit to India, Indian drug makers in China see hopes of a wider opening for their quality generics, instead of a haven for cheap counterfeit cancer drugs.

China Develops Field Test Kits For Ebola

A researcher said China has produced portable kits to test for the presence of the Ebola virus in the field and that these would be deployed first in Sierra Leone.

Insider Says GSK's Reilly To Be Deported Not Jailed?

A source with inside knowledge said GlaxoSmithKline's former China head, a British citizen, would not serve any jail time in China but would be deported from the country instead.

Canon Develops Imaging Device For Blood Vessels

Canon plans to begin clinical trials by the end of the year for a diagnostic-imaging device capable of providing a clear picture of blood vessels.

Help the Doctor

CHARLES KENNEY and JACK COCHRAN, MD In recent weeks and months a number of articles have delved into the issue with a sense of seriousness and purpose that the doctor crisis deserves. Progress on reducing unnecessary pressures on physicians is painfu...

Regeneron Is Regenerating Growth In My Portfolio Once Again

By Abba's Aces:I recently closed my position in United Rentals, Inc. (NYSE:URI) from my growth portfolio because I felt that I had a pretty good profit at the time and wanted to lock up some gains. I ended up buying shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) because I wanted to buy back into the growth stock. Regeneron is a fully integrated biopharmaceutical company that discovers, in...

Why Biogen Stock Is Still An Investment Opportunity

By Arie Goren:Biogen Idec Inc. (NASDAQ:BIIB) will continue to benefit from the growing demand for its products, and from its top-quality pipeline that should sustain long-term growth. BIIB's stock started its strong rally in mid-2010 and continued to perform very well. Since the beginning of the year, BIIB's stock has already gained 17.8%, and since the start of 2012, the stock has recorded an ast...

Belviq Sales Recover From Holiday Dip

By Spencer Osborne:Arena Pharmaceuticals' (NASDAQ:ARNA) anti-obesity pill Belviq saw a full recovery from a holiday dip in sales last week with a 15% gain this week. Sales in the most recent week demonstrated a full recovery plus a modest increase above the pre-holiday sales levels. The rise was just as expected as the previous dip for investors that track the equity, but that does not stop the st...

Restoring My Growth Portfolio With Restoration Hardware By Closing Out Celgene

By Abba's Aces:I recently closed my position in Celgene Corporation (NASDAQ:CELG) from my growth portfolio because I felt that I had a pretty good profit at the time and wanted to lock up some gains. I ended up buying shares of Restoration Hardware (NYSE:RH) because I wanted to buy back into the growth stock. Restoration Hardware Holdings Inc, together with its subsidiaries, is a luxury home furni...

Sanofi's New Drug Is Potentially A Game Changer

By Apex Financial Consultants:Sanofi SA (NYSE:SNY) is all set to make dengue a vaccine-preventable disease after 20 years of research and industrial commitment. In clinical trials the company's experimental vaccine protected children from all four types of the mosquito-borne illness and considerably reduced the risk of infection by 60.8%. The vaccine also reduced the risk of hospitalization by 80....

Update: Cellceutix Calls Out To President Obama About Brilacidin

By KarinCA:A press release by Cellceutix Corp. (OTCQB:CTIX) came out on September 19, 2014 with an unusually bold Heading. Cellceutix to President Obama: We Have The Tools And Will Rise Up To The Challenge To Prevent Antibiotic Resistant Bacteria Becoming A Serious Threat to Public Health. Leo Ehrlich, the CEO of CTIX appears to be quite confident in the upcoming unblinding of the Brilacidin data ...

A physician’s last patient before retirement

Mrs. D was my last patient. I retired several months ago, and for some time prior I informed my patients so as to give them time to decide where they would like their follow-up care. Mrs. D was an elderly lady who I first met in the ER several years prior after a fall resulting […]

The quixotic quest for precision in medicine

88.2% of all statistics are made up on the spot. - Victor Reeves There’s a growing movement in medicine in general and imaging in particular which wishes to attach a number to everything. It no longer suffices to say, “You’re at moderate risk for pulmonary embolism (PE).” We must quantify our qualification. Continue reading ... […]

The science behind superwheat

  First published on 30 Jul 2013An animated short video where NIAB's Richard Horsnell explains how synthetic hexaploid wheat is created and how it could offer new sources of genetic diversity to improve wheat crops in the UK and Europe.

MKSAP: 69-year-old woman with a lump under her arm

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians. A 69-year-old woman is evaluated for a lump under her arm found on self-examination. She is otherwise healthy and has no other symptoms. Medical and family histories are unremarkable, and she takes no medications. On physical examination, temperature is 37.4 °C […]

The pressure to admit patients from the ER will only grow

Once again government regulators have put in place well-meaning rules without anticipating the consequences. We all hate sitting around in the emergency department waiting to be seen and to be treated. On October 15, 2014 as part of the new Affordable Health Care Act and the patient satisfaction portion, hospital ERs will have about 180 […]

Civitas Solutions - No Taste For This Leveraged Healthcare Play

By The Value Investor:Civitas Solutions (NYSE:CIVI) provides home- and community-based health services for those having intellectual, physical or other needs.The company develops tailored service plans for these patients to live in a non-institutional environment with less restrictive settings.While the business does fairly well, although operating margins are slim, the leverage employed even afte...

India’s Micro Labs Gets FDA Import Alert For Goa Unit

FDA inspections are a central focus for Indian drug industry. The wait continues on the results of the agency’s inspections at Sun Pharma’s Halol site, but another firm, Micro Labs was served an Import Alert for GMP violations at its Goa manufact...

Who are the best judges of physician quality?

In a new Forbes article, David Shaywitz ponders whether patients are the best judges of physician quality. This is a very interesting question, not because the answer is elusive, but because the question itself is rather unusual, and may prove to be the harbinger of a new way of thinking about health care. The question raised by Dr. Shaywitz […]

Saturday 20th September 2014

The dreaded post-visit calls: Are they worth it?

Just the other day I received a somewhat anxious-sounding phone message from a patient of mine, approximately 72 hours after her office visit with me, and about 24 hours after I had already gone over all of her lab results from the visit with her. She sounded quite distressed, and said she’d received a message […]

The dreaded post-visit call: Are they worth it?

Just the other day I received a somewhat anxious-sounding phone message from a patient of mine, approximately 72 hours after her office visit with me, and about 24 hours after I had already gone over all of her lab results from the visit with her. She sounded quite distressed, and said she’d received a message […]

To Curb Medical Costs, Let Market Forces Do Their Job

Competition and a focus on effectiveness rather than price will lower America’s healthcare bill.

Sometimes doctoring reveals my failings as a human being

We were intimate. As intimate as a doctor and patient can become.  He had long outlived his wife and there were no children, no family, just friends.  When he first came to me he was lively and active, but the years took their toll.  Our visits became more regular.  Every six months.  Then every three. […]

Not knowing what we don’t know: How can we help doctors?

Dr. Daniela Drake writes an provocative and bold piece on the plight of doctors in America and the impact it has on patient care: “Why Your Doctor Feels Like a ‘Beaten Dog’.” Though health care is very bureaucratic with administrative paperwork, huddles, and hassles, her linkage of how patients were neglected as a consequence of […]

A Repudiation Of Advance Cell Technology's 'Whisper' Results

By JMY Investments:Investors found out last week that Advanced Cell Technology (OTCQB:ACTCD) is changing its name to Ocata Therapeutics. We also found out the company plans to increase its authorized common shares by 60%. It is well known Advanced Cell Technology (or ACT for short) needs to obtain funding for its Phase II trials for Dry Age Related Macular Degeneration and Stargardt's Macular Dege...


Search BioPortfolio:
Loading
Advertisement
Advertisement